In cultured AML cells, upon metabolic stress induced by the pyruvate dehydrogenase kinase-1 (PDK1) inhibitor dichloroacetate (DCA), TP53 is activated in an AMPK-dependent manner and regulates the transcription of its metabolic targets, while it also causes cell cycle arrest [54]. This evidence concerns the gene TP53 and acute myeloid leukemia.